Vascular Pharmacology

CRISPR-based genome editing of smooth muscle cells: Disease models, therapeutic applications, and future perspectives

By Qianqian Ding, Xinyi Zhou, Eric N. Olson, Ning Liu

ReviewInterventions

The paper

Qianqian Ding, Xinyi Zhou, Eric N. Olson, Ning Liu

The University of Texas Southwestern Medical Center

Vascular Pharmacology, 3 Oct 2026

doi.org/10.1016/j.vph.2026.107709 PubMed 42829072

bioRxiv2 Oct 2026
Deleting the mechanosensitive channel Piezo1 prevents gut motility decline in aging mice
Science Advances7 Oct 2026
Support cells worsened disease features in lab-grown human vessels
Nature Communications2 Oct 2026
Base editing of the lamin farnesylation motif rescues progeria phenotypes in organoids